series-c-plus
Stage
2
Investors
About
Adimab provides a proprietary yeast-based antibody discovery and engineering platform that enables biopharma partners to develop therapeutic antibodies and proteins for clinical use.
Explore Adimab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.